These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35482914)

  • 1. Nonremission After Electroconvulsive Therapy in Individuals With Major Depression: Role of Borderline Personality Disorder.
    Hein M; Mungo A; Loas G
    J ECT; 2022 Dec; 38(4):238-243. PubMed ID: 35482914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of relapse within 6 months associated with borderline personality disorder in major depressed individuals treated with electroconvulsive therapy.
    Hein M; Mungo A; Loas G
    Psychiatry Res; 2022 Aug; 314():114650. PubMed ID: 35659671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.
    Feske U; Mulsant BH; Pilkonis PA; Soloff P; Dolata D; Sackeim HA; Haskett RF
    Am J Psychiatry; 2004 Nov; 161(11):2073-80. PubMed ID: 15514409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of the diagnostic method for borderline personality disorder on the acute response and the risk of early relapse in major depressed individuals treated with ECT: A systematic literature review].
    Bamouss A; Mungo A; Hein M
    Encephale; 2024 Feb; ():. PubMed ID: 38311474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder.
    Lee JH; Kung S; Rasmussen KG; Palmer BA
    J ECT; 2019 Mar; 35(1):44-47. PubMed ID: 30113988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?
    DeBattista C; Mueller K
    J ECT; 2001 Jun; 17(2):91-8. PubMed ID: 11417933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal points of preanesthesia evaluations for electroconvulsive therapy in patients with depression: a retrospective analysis of clinical characteristics in nonremission.
    Zou L; Li X; Chen Q; Lv F; Min S
    BMC Anesthesiol; 2022 May; 22(1):163. PubMed ID: 35619081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borderline Personality Disorder and Outcome of Electroconvulsive Therapy in Patients With Depression: A Systematic Review.
    Nicolini AP; Sienaert P
    J ECT; 2023 Jun; 39(2):74-80. PubMed ID: 36821825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of remission after electroconvulsive therapy in unipolar major depression.
    Dombrovski AY; Mulsant BH; Haskett RF; Prudic J; Begley AE; Sackeim HA
    J Clin Psychiatry; 2005 Aug; 66(8):1043-9. PubMed ID: 16086621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcomes of Electroconvulsive Therapy for Depressed Patients With and Without Borderline Personality Disorder: A Retrospective Cohort Study.
    Yip AG; Ressler KJ; Rodriguez-Villa F; Siddiqi SH; Seiner SJ
    J Clin Psychiatry; 2021 Jan; 82(2):. PubMed ID: 33471448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study.
    Kaster TS; Goldbloom DS; Daskalakis ZJ; Mulsant BH; Blumberger DM
    Brain Stimul; 2018; 11(1):204-212. PubMed ID: 29111076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-suicidal self-injury and electroconvulsive therapy: Outcomes in adolescent and young adult populations.
    Rootes-Murdy K; Carlucci M; Tibbs M; Wachtel LE; Sherman MF; Zandi PP; Reti IM
    J Affect Disord; 2019 May; 250():94-98. PubMed ID: 30844603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECT revisited: impact on major depression in borderline personality disorder.
    Gescher DM; Cohen S; Ruttmann A; Malevani J
    Aust N Z J Psychiatry; 2011 Nov; 45(11):1003-4. PubMed ID: 21981774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electroconvulsive therapy for major depression in borderline personality disorder].
    Gescher DM; Malevani J
    Fortschr Neurol Psychiatr; 2012 Mar; 80(3):141-8. PubMed ID: 21678232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal ideation and ECT, ECT and suicidal ideation: A register study.
    Sienaert P; Brus O; Lambrichts S; Lundberg J; Nordanskog P; Obbels J; Verspecht S; Vansteelandt K; Nordenskjöld A
    Acta Psychiatr Scand; 2022 Jul; 146(1):74-84. PubMed ID: 35279825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    J Affect Disord; 2009 Jul; 116(1-2):106-12. PubMed ID: 19081638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borderline personality traits do not influence response to TMS.
    Ward HB; Yip A; Siddiqui R; Morales OG; Seiner SJ; Siddiqi SH
    J Affect Disord; 2021 Feb; 281():834-838. PubMed ID: 33229022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity.
    Steinholtz L; Reutfors J; Brandt L; Nordanskog P; Thörnblom E; Persson J; Bodén R
    J Affect Disord; 2021 Sep; 292():276-283. PubMed ID: 34134026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder.
    Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Schoevers RA; Denys D; Ruhé HG; van Wingen GA
    J Affect Disord; 2022 Aug; 310():156-161. PubMed ID: 35490877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.